Eugene Storozynsky, M.D., Ph.D., FACC

Dr. Storozynsky is a Professor of Medicine in Cardiology and the Director of the MUSC Cardio-Oncology Program. He received an MD/PhD from the University of Rochester School of Medicine and Dentistry and completed his post-graduate training in internal medicine and cardiology with a special focus on advanced heart failure at the University of Rochester Medical Center. He is board-certified in cardiology, echocardiography, and heart failure/transplant cardiology.

Dr. Storozynsky leads the MUSC Cardio-Oncology Program, a joint program between the MUSC Heart and Vascular Institute and the Hollings Cancer Center. This is a comprehensive multidisciplinary program that identifies and treats patients who are at increased risk of heart related complications prior to a patient's cancer treatment, during cancer treatment, and in cancer survivors as the risk of long-term cardiovascular complications, although quite small, are not insignificant when they occur.

Dr. Storozynsky takes care of adult patients with congestive heart failure that can occur from coronary artery disease, valvular heart disease, and inflammatory/infiltrative processes. He has expertise in managing patients s/p heart transplantation as well as mechanical heart pumps. Dr. Storozynsky has special interest and expertise in using novel techniques of cardiovascular imaging including 3D echocardiography and global longitudinal strain in the management of cancer patients, performing native heart biopsies, and evaluating patients with abnormal heart masses.

Dr. Storozynsky has authored more than 50 scientific articles. His current research interests include examining clinical predictors of chemotherapy-associated cardiotoxicity, identifying and implementing optimal approaches to the treatment of chemotherapy induced hypertension, and using artificial intelligence to identify subclinical markers of heart disease by examining existing radiologic tests of patients treated with chemo and radiation therapy.